Quick Takeaways Why It Matters? Liavium-CA1 gives Pegasus (PRN Pharmacal) a first-in-class, branded neurology asset in a completely underserved niche, which should support premium pricing and strong loyalty among neurologists and specialty practices that see CM/SM dogs. B...
Quick Takeaways Why It Matters? Gallant is on track to create one of the first mass‑market, disease‑modifying OA biologics in companion animals, shifting regenerative medicine from niche referral centers into everyday general practice via a simple, ready‑to‑use IV product. ...
